{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:51:40Z","timestamp":1790196700720,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijantimicag.2020.105875","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T19:41:58Z","timestamp":1578512518000},"page":"105875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Complications of peripheral venous catheters: The need to propose an alternative route of administration"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-1551","authenticated-orcid":false,"given":"Morgane","family":"Mailhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Brouqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Michelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Raoult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Parola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Lagier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.105875_bib0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jemermed.2017.10.005","article-title":"Appropriateness and complications of peripheral venous catheters placed in an emergency department","volume":"54","author":"Guihard","year":"2018","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0002","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/archinte.1994.00420160062008","article-title":"Reduction of unnecessary intravenous catheter use. Internal medicine house staff participate in a successful quality improvement project","volume":"154","author":"Parenti","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0003","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.annemergmed.2013.02.022","article-title":"Half of all peripheral intravenous lines in an Australian tertiary emergency department are unused: pain with no gain?","volume":"62","author":"Limm","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13012-018-0792-z","article-title":"Implementation of a knowledge mobilization model to prevent peripheral venous catheter-related adverse events: PREBACP study\u2014a multicenter cluster-randomized trial protocol","volume":"13","author":"Blanco-Mavillard","year":"2018","journal-title":"Implement Sci"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jhin.2008.12.012","article-title":"Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates","volume":"72","author":"Tacconelli","year":"2009","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0006","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ancard.2018.08.025","article-title":"Incidence and risk factors of peripheral venous catheter-related adverse events in cardiology department of a Tunisian university hospital: a prospective observational study","volume":"68","author":"Ghali","year":"2019","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0007","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4103\/njcp.njcp_337_17","article-title":"Phlebitis-related peripheral venous catheterization and the associated risk factors","volume":"21","author":"Atay","year":"2018","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00892-18","article-title":"Short-term peripheral venous catheter-related bloodstream infections: evidence for increasing prevalence of Gram-negative microorganisms from a 25-year prospective observational study","volume":"62","author":"Ripa","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0009","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/j.jhin.2018.06.010","article-title":"Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality","volume":"100","author":"Saliba","year":"2018","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jhin.2007.06.017","article-title":"Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital","volume":"67","author":"Pujol","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0011","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/cid\/cix562","article-title":"Short-term peripheral venous catheter-related bloodstream infections: a systematic review","volume":"65","author":"Mermel","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2020.105875_bib0012","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/cix345","article-title":"Rewiring microbiology and infection","volume":"65","author":"Raoult","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2020.105875_bib0013","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/cid\/cix403","article-title":"From expert protocols to standardized management of infectious diseases","volume":"65","author":"Lagier","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0014","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jhm.2389","article-title":"International prevalence of the use of peripheral intravenous catheters","volume":"10","author":"Alexandrou","year":"2015","journal-title":"J Hosp Med"},{"issue":"6 Suppl","key":"10.1016\/j.ijantimicag.2020.105875_bib0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.7326\/M15-0744","article-title":"The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND\/UCLA appropriateness method","volume":"163","author":"Chopra","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0016","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0148607116676593","article-title":"Subcutaneous infusion of fluids for hydration or nutrition: a review","volume":"42","author":"Caccialanza","year":"2018","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0017","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1177\/0148607116629790","article-title":"Safety and efficacy of subcutaneous parenteral nutrition in older patients: a prospective randomized multicenter clinical trial","volume":"41","author":"Zaloga","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0018","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/jhin.1998.0537","article-title":"Subcutaneous fluid administration\u2014better than the intravenous approach?","volume":"41","author":"Jain","year":"1999","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7748\/nop2011.06.23.5.16.c8528","article-title":"Use of hypodermoclysis to manage dehydration","volume":"23","author":"Scales","year":"2011","journal-title":"Nurs Older People"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.11.017","article-title":"Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks","volume":"21","author":"Forestier","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0021","first-page":"151","article-title":"Tolerance of subcutaneously administered antibiotics: a French national prospective study","volume":"46","author":"Roubaud-Baudron","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0022","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jinf.2012.09.004","article-title":"Prolonged subcutaneous high dose (1 g bid) of ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection","volume":"65","author":"Ferry","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0023","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/jac\/dkz104","article-title":"Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients","volume":"74","author":"Pouderoux","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0024","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2020.105875_bib0025","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/clinids\/13.Supplement_2.S160","article-title":"Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci","volume":"13","author":"Stamboulian","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0026","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0027","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ahj.2012.11.006","article-title":"Partial oral treatment of endocarditis","volume":"165","author":"Iversen","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0028","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0029","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cmi.2016.04.003","article-title":"Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non-severely ill patients","volume":"22","author":"Mzabi","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijantimicag.2013.05.002","article-title":"Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim\/sulfamethoxazole and clindamycin\u2014preliminary report","volume":"42","author":"Casalta","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0031","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2019.06.006","article-title":"High-dose trimethoprim\u2013sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis","volume":"54","author":"Tissot-Dupont","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0032","series-title":"Antibiotic resistance. Implications for global health and novel intervention strategies: workshop summary","year":"2010"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0033","series-title":"Antibiotic resistance threats in the United States","year":"2019"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(18)30800-4","article-title":"Attributable deaths caused by infections with antibiotic-resistant bacteria in France","volume":"19","author":"Raoult","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105875_bib0036","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12879-017-2536-0","article-title":"Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study","volume":"17","author":"Sato","year":"2017","journal-title":"BMC Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:34:42Z","timestamp":1760376882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920300054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0924857920300054"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105875","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications of peripheral venous catheters: The need to propose an alternative route of administration","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105875"}}